about
Treating nausea and vomiting in palliative care: a reviewPatient considerations in the management of chronic constipation: focus on prucaloprideOpioid-induced constipation: advances and clinical guidanceDisorders of gastrointestinal hypomotilityChronic opioid induced constipation in patients with nonmalignant pain: challenges and opportunitiesEffectiveness of prokinetic agents against diseases external to the gastrointestinal tract[Is the pharmacological treatment of constipation in palliative care evidence based? : a systematic literature review].Prucalopride improves bowel function and colonic transit time in patients with chronic constipation: an integrated analysis.Stomach dysfunction in diabetes mellitus: emerging technology and pharmacologyLinaclotide: A new drug for the treatment of chronic constipation and irritable bowel syndrome with constipationEfficacy and safety of oral prucalopride in women with chronic constipation in whom laxatives have failed: an integrated analysisSerotonin signalling in the gut--functions, dysfunctions and therapeutic targets.Serotonergic Mechanisms Regulating the GI Tract: Experimental Evidence and Therapeutic RelevanceGastroparesis and functional dyspepsia: excerpts from the AGA/ANMS meetingReview article: new receptor targets for medical therapy in irritable bowel syndromePrucalopride: the evidence for its use in the treatment of chronic constipation.Prucalopride-associated acute tubular necrosis.Prucalopride for constipation.Efficacy and safety of prucalopride in patients with chronic noncancer pain suffering from opioid-induced constipationSystematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disordersRandomised clinical trial: the efficacy of prucalopride in patients with chronic intestinal pseudo-obstruction--a double-blind, placebo-controlled, cross-over, multiple n = 1 studyBloating and functional gastro-intestinal disorders: where are we and where are we going?Functional dyspepsia.Irritable bowel syndrome: the evolution of multi-dimensional looking and multidisciplinary treatmentsLX-1031, a tryptophan 5-hydroxylase inhibitor, and its potential in chronic diarrhea associated with increased serotoninClinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation--a 12-week, randomized, double-blind, placebo-controlled study.Translating 5-HT receptor pharmacology.Prucalopride.The Pharmacology of TD-8954, a Potent and Selective 5-HT(4) Receptor Agonist with Gastrointestinal Prokinetic Properties.Role of prucalopride, a serotonin (5-HT(4)) receptor agonist, for the treatment of chronic constipation.Systematic review with meta-analysis: highly selective 5-HT4 agonists (prucalopride, velusetrag or naronapride) in chronic constipation.Diagnosis and treatment of chronic constipation--a European perspective.Characteristics of 5-hydroxytryptamine receptors involved in contraction of feline ileal longitudinal smooth muscle.Assessment of the cardiac safety of prucalopride in healthy volunteers: a randomized, double-blind, placebo- and positive-controlled thorough QT study.A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia.Early investigational therapeutics for gastrointestinal motility disorders: from animal studies to Phase II trials.Prucalopride for the treatment of ileus.Activation of colonic mucosal 5-HT(4) receptors accelerates propulsive motility and inhibits visceral hypersensitivity.The effects of prucalopride on postoperative ileus in guinea pigs.Efficacy and Safety of Prucalopride in Chronic Constipation: An Integrated Analysis of Six Randomized, Controlled Clinical Trials.
P2860
Q24635649-40AE2511-CACB-4117-8093-757FB6CF16E9Q26741304-8F7B96A6-E3DF-4404-B302-79FC59941C75Q26765571-57F5D8E3-0218-471C-80C6-5DE5D784C2FFQ28070278-9825C644-A6EB-46F3-9434-3687B5B89EC6Q28083547-785E3B8F-67E5-49B3-A6B5-FCE25C22A906Q28235297-044632B8-D67F-4ACA-9F9A-D398FA1906A2Q31104772-CB34B553-D1A7-488A-BA2E-975DDE0705C0Q33461315-487DDEAE-EA85-431D-BEAC-E9F8303AC9E9Q33674557-7ECF402C-2D3B-49C0-ABA9-D0A13130DC0FQ33695487-078852B1-0CDC-4A43-A7A8-6A49A5588273Q33695505-95FACAF6-28AF-4A29-B73C-4FF394F2840DQ33724343-164A5343-8794-4FF7-8EE6-70CFF763F82EQ33926234-E010EEDB-705C-4FFE-9DA4-26110CD33CA1Q33941371-24D9CE06-C486-4781-8E97-53DCC826353EQ33959307-606EABEB-E42F-43F3-A3AD-B9BDC46B9296Q33973983-31D25A4F-C368-46E5-9D3F-D73EE7ECE4C9Q34047629-3DB9FEAD-FCED-4386-A48F-49144D5313BDQ34094831-B96B5A1A-7F3D-4E01-A810-ADCCBBB2B14EQ34146166-7124C8B0-9BD4-4FBF-A212-7E3D0FD9FAC3Q34166903-87BE9702-32A0-47D6-B8BB-A73DD6E675BCQ34230555-78178710-16D3-4B6A-B243-9D2AF20D01DBQ34366956-9DBBB6AE-741C-4585-96EA-6E9000D0B8ECQ34409166-DD45114C-75CC-4F7A-94A2-11B47D7DA5D8Q34660338-4B3DFF3B-5A3D-478B-96D3-7C1C7D24AD54Q34790812-B2D7F611-0CB3-4C1B-9B80-D1058FD32937Q34889324-5B8BA05B-0762-40D8-BD27-E0120EE04DD8Q35012378-A2DC6341-5F2F-425A-B392-D073C6A9E157Q35012772-8E8C9614-1809-4DA3-B871-81232EA7F407Q35025872-FBF32C47-D77E-4D14-9FC0-C1878208FBBFQ35026383-6AEB1E86-39FE-4ED0-98AE-C6A54F7AC935Q35059682-FA277B61-8382-498D-B97B-3C1357121237Q35207439-F7F96EBF-B1AC-4AD9-B959-F38819BFAA80Q35569347-18FB7435-A7B1-44C4-83D2-277FD0A3DD14Q35718568-CCF5CEC1-7732-4660-8A19-1BE2FB98224EQ35939253-DDDDDC56-F25F-4118-BEE8-FBA53CA3C8FAQ36082843-0321D3AB-0B05-4EEC-8A9A-29F539D196E8Q36302121-C60869DD-6BFE-4856-B058-AC9924D246B7Q36336675-AFDA97C2-AB20-41C0-B924-89D56249FF49Q36872925-816B41DF-40EE-40E4-B8C8-785B204D329BQ37092661-CF2F4E17-2821-4968-99EE-44567B8E0B7A
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
5-HT4 receptor agonists: similar but not the same.
@ast
5-HT4 receptor agonists: similar but not the same.
@en
5-HT4 receptor agonists: similar but not the same.
@nl
type
label
5-HT4 receptor agonists: similar but not the same.
@ast
5-HT4 receptor agonists: similar but not the same.
@en
5-HT4 receptor agonists: similar but not the same.
@nl
prefLabel
5-HT4 receptor agonists: similar but not the same.
@ast
5-HT4 receptor agonists: similar but not the same.
@en
5-HT4 receptor agonists: similar but not the same.
@nl
P2093
P2860
P1476
5-HT4 receptor agonists: similar but not the same.
@en
P2093
J A J Schuurkes
J H De Maeyer
R A Lefebvre
P2860
P304
P356
10.1111/J.1365-2982.2007.01059.X
P577
2008-02-01T00:00:00Z